Voya Investment Management LLC Anavex Life Sciences Corp. Transaction History

Voya Investment Management LLC

$78.9 Billion
Q4 2024

A detailed history of Voya Investment Management LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Voya Investment Management LLC holds 22,775 shares of AVXL stock, worth $198,825. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,775

Previous 25,080 9.19%

Holding current value

$198,825

Previous $142,000 71.83%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$5.11 - $12.56 $11,778 - $28,950	-2,305 Reduced 9.19%	22,775 $244,000
Q3 2024 Feb 07, 2025	BUY	$4.11 - $7.04 $287 - $492	70 Added 0.28%	25,080 $142,000
Q3 2024 Nov 14, 2024	BUY	$4.11 - $7.04 $287 - $492	70 Added 0.28%	25,080 $142,000
Q2 2024 Feb 07, 2025	BUY	$3.39 - $5.02 $1,013 - $1,500	299 Added 1.21%	25,010 $105,000
Q2 2024 Dec 03, 2024	SELL	$3.39 - $5.02 $237 - $351	-70 Reduced 0.28%	25,010 $105,000
Q2 2024 Aug 14, 2024	BUY	$3.39 - $5.02 $1,013 - $1,500	299 Added 1.21%	25,010 $105,000
Q1 2024 Feb 07, 2025	SELL	$4.55 - $6.75 $1,678 - $2,490	-369 Reduced 1.47%	24,711 $125,000
Q1 2024 Dec 06, 2024	SELL	$4.55 - $6.75 $1,678 - $2,490	-369 Reduced 1.47%	24,711 $125,000
Q1 2024 May 15, 2024	SELL	$4.55 - $6.75 $17,581 - $26,082	-3,864 Reduced 13.52%	24,711 $125,000
Q4 2023 Feb 07, 2025	BUY	$5.04 - $9.95 $3,240 - $6,397	643 Added 2.3%	28,575 $266,000
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $3,240 - $6,397	643 Added 2.3%	28,575 $266,000
Q2 2023 Feb 07, 2025	BUY	$7.66 - $9.5 $11,865 - $14,715	1,549 Added 5.87%	27,932 $227,000
Q2 2023 Aug 14, 2023	BUY	$7.66 - $9.5 $11,865 - $14,715	1,549 Added 5.87%	27,932 $227,000
Q1 2023 Feb 07, 2025	BUY	$8.32 - $11.75 $10,840 - $15,310	1,303 Added 5.2%	26,383 $226,000
Q3 2022 Feb 07, 2025	BUY	$8.9 - $12.86 $11,596 - $16,756	1,303 Added 5.2%	26,383 $272,000
Q1 2022 May 16, 2022	BUY	$9.74 - $17.69 $12,662 - $22,997	1,300 Added 5.18%	26,383 $325,000
Q4 2021 Feb 14, 2022	BUY	$16.88 - $23.31 $10,836 - $14,965	642 Added 2.63%	25,083 $435,000
Q2 2021 Aug 16, 2021	SELL	$10.16 - $28.86 $10,322 - $29,321	-1,016 Reduced 3.99%	24,441 $559,000
Q1 2021 May 17, 2021	BUY	$5.17 - $16.13 $6,059 - $18,904	1,172 Added 4.83%	25,457 $381,000
Q4 2020 Feb 16, 2021	BUY	$4.01 - $7.58 $22,921 - $43,327	5,716 Added 30.78%	24,285 $131,000
Q2 2020 Aug 14, 2020	SELL	$2.62 - $5.2 $19,896 - $39,488	-7,594 Reduced 29.03%	18,569 $91,000
Q4 2019 Feb 14, 2020	BUY	$2.31 - $3.14 $17,622 - $23,955	7,629 Added 41.16%	26,163 $68,000
Q2 2019 Aug 14, 2019	BUY	$2.75 - $3.7 $50,968 - $68,575	18,534 New	18,534 $62,000
Q2 2018 Aug 14, 2018	SELL	$2.08 - $4.26 $37,897 - $77,617	-18,220 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.42 - $4.87 $62,312 - $88,731	18,220	18,220 $75,000

Others Institutions Holding AVXL

# of Institutions

188

Shares Held

29.2M

Call Options Held

894K

Put Options Held

821K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $680M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Anavex Life Sciences Corp. Transaction History